Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about psilocybin therapy

Recent news which mentions psilocybin therapy

Kaya Holdings Advocates For Psilocybin As FDA Rejects MDMA For PTSD Treatment
Tickers KAYS NEWS
Tags News Cannabis Market News
From Benzinga
Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions
Tickers NEWS NUMIF
Tags Psychedelics Research Legal NUMIF
From Benzinga
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Tickers ATAI CMND CMPS CYBN
Tags Cannabis Financing GHRS
From Benzinga
Washington Doctor Vs. DEA For Lawful Use Of Psilocybin To Treat Terminally Ill Patients
Tickers NEWS
Tags Market News Benzinga Psychedelics
From Benzinga
Canadian At-Home Microdose Psilocybin Clinical Trial Finalized, Here Are The Details
Tags News Apex Labs Psilocybin Microdosing
From Benzinga
Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment
Tickers RVVTF
Tags News Methamphetamine Use Disorder Cannabis
From Benzinga
Canada's Ongoing Struggle For Access To Natural Psilocybin As A Therapeutic Nabs Business Support
Tickers TRUFF
Tags News Guidance Legal
From Benzinga
Canadian Psychedelics Company Launches Take-Home Psilocybin Trial For Some 300 Participants
Tags Market News Global psilocybin therapy
From Benzinga
Virginia Psychedelics: Legalizing Medical Use Of Psilocybin Gets A Thumbs Down
Tags News Psychedelics Legalization Psychedelics
From Benzinga
2023 Could Be Make Or Break For Psychedelics In Missouri, This GOP Lawmaker Is Pushing For Change
Tags Legal News Market News
From Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
Tickers ATAI AWKNF CMND CMPS
Tags CMPS Treatment Resistant Depression Markets
From Benzinga
Oregon's Final Rules For Psilocybin Services Are Ready, Learn What To Expect
Tags Oregon Health Authority Government Regulations
From Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
Tickers KONEF NMLSF
Tags Market News NMLSF psilocybin therapy
From Benzinga
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
Tags News Benzinga Markets
From Benzinga
Potential Road To At-Home Psychedelics Use Permits: Low Dosing's Positive Outcomes In Phase 1 Trial
Tags News Diamond Therapeutics Inc/ Non/Hallucinogenic Psychedelics
From Benzinga
Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far
Tickers CMPS
Tags Psychedelic/Assisted Therapies CMPS Psychedelics
From Benzinga
DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again
Tickers CSA DEA
Tags psilocybin therapy Market News Cannabis
From Benzinga
In Oregon You Can Get Trained To Be A Licensed Psilocybin Therapy Provider
Tags Fluence News Benzinga
From Benzinga
Cannabis & Psychedelics As Effective Adjunct Medicine To Breast Cancer Therapy? Studies Say Yes
Tags Benzinga Markets Psychedelics
From Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: What Science Is Saying
Tickers CMPS
Tags smoking cessation alcohol addiction CMPS
From Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: The Legal Situation
Tags USDA Government Regulations
From Benzinga
Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction
Tickers RVVTF
Tags Psilocin Pharma Corp LTS LOHMANN Therapie/Systeme AG Dr/ Christopher Nicholas
From Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
Tickers MSSTF
Tags Global psilocybin therapy James Lanthier
From Benzinga
Psychedelics Companies Are Teaming Up To Offer Access Veterans
Tickers AWKNF RVLWF
Tags Management Wake Network Psychedelic Retreats
From Benzinga
Cathie Wood's Psychedelics Fund ARK Analyzes The Sector's Present & Future And Likes What It Sees
Tickers ATAI
Tags Benzinga Markets Psychedelics
From Benzinga
Study Finds Psilocybin Anti-Depression Effects Last At Least One Year
Tags Cannabis major depressive disorder psilocybin therapy
From Benzinga
The Case For Psilocybin Therapy And Depression
Tags Markets Benzinga depression
From Benzinga
ATAI Life Sciences Announces New Program To Discover Next-Generation Mental Health Treatments
Tickers ATAI
Tags Penny Stocks Benzinga Markets
From Benzinga
Psilocybin Therapy Combined With SSRI Antidepressants Is Possible, COMPASS Study Confirms
Tickers CMPS
Tags psyhedelics Cannabis Market News
From Benzinga
Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways
Tickers ATAI CMPS
Tags Health Care Benzinga Markets
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.